Bioequivalence Study of 2 Sizes of SHR4640 Tablets Orally in Healthy Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The study is being conducted to evaluate the pharmacokinetic, and safety of two sizes of SHR4640 tablets in healthy adults, to explore the bioequivalence between two sizes of SHR4640 tablets.
Epistemonikos ID: 097f2918c1453c6e25512e947dbd3180fa13ef7e
First added on: May 15, 2024